Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

Ali Akbar Alizadeh ^1,2 , Behzad Jafari ³, Siavoush Dastmalchi ^1,4 *

Cited by CrossRef: 2

1- Asadi P, Khodarahmi G, Rafiee A, Aliomrani M, Hassanzadeh F. Design, Synthesis, Bioactivity Analyses, and Molecular Docking Study of Triazine-Tyrosine Based Derivatives as Drugs like Fingolimod for Treatment of Multiple Sclerosis. Polycyclic Aromatic Compounds. 2024;44(4):2292 [Crossref]

2- Fajriaty I, Fidrianny I, Kurniati N, Fauzi N, Mustafa S, Adnyana I. In vitro and in silico studies of the potential cytotoxic, antioxidant, and HMG CoA reductase inhibitory effects of chitin from Indonesia mangrove crab (Scylla serrata) shells. Saudi Journal of Biological Sciences. 2024;31(5):103964 [Crossref]